Prolactinoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Anmol Pitliya (talk | contribs)
No edit summary
Anmol Pitliya (talk | contribs)
No edit summary
Line 12: Line 12:
#'''[[Physiological]]:'''
#'''[[Physiological]]:'''
#*Normal [[pregnancy]]<ref name="pmid910825">{{cite journal| author=Rigg LA, Lein A, Yen SS| title=Pattern of increase in circulating prolactin levels during human gestation. | journal=Am J Obstet Gynecol | year= 1977 | volume= 129 | issue= 4 | pages= 454-6 | pmid=910825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=910825  }} </ref>
#*Normal [[pregnancy]]<ref name="pmid910825">{{cite journal| author=Rigg LA, Lein A, Yen SS| title=Pattern of increase in circulating prolactin levels during human gestation. | journal=Am J Obstet Gynecol | year= 1977 | volume= 129 | issue= 4 | pages= 454-6 | pmid=910825 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=910825  }} </ref>
#'''[[Pathological]]:'''[[Pituitary tumors]] (other than prolactinoma):<ref name="pmid15316045">{{cite journal| author=Levy A| title=Pituitary disease: presentation, diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue=  | pages= iii47-52 | pmid=15316045 | doi=10.1136/jnnp.2004.045740 | pmc=1765669 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316045  }} </ref>
#'''[[Pathological]]:'''[[Pituitary tumors]] (other than [[prolactinoma]]):<ref name="pmid15316045">{{cite journal| author=Levy A| title=Pituitary disease: presentation, diagnosis, and management. | journal=J Neurol Neurosurg Psychiatry | year= 2004 | volume= 75 Suppl 3 | issue=  | pages= iii47-52 | pmid=15316045 | doi=10.1136/jnnp.2004.045740 | pmc=1765669 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15316045  }} </ref>
#*[[Somatotroph adenoma]]: [[Acromegaly]]
#*[[Somatotroph adenoma]]: [[Acromegaly]]
#*[[ACTH-secreting tumor|Corticotroph adenoma]]: [[Cushing's syndrome]]
#*[[ACTH-secreting tumor|Corticotroph adenoma]]: [[Cushing's syndrome]]
#*Supra [[Sella turcica|seller]] tumors(tumors present in region of [[pituitary stalk]])
#*Supra [[Sella turcica|seller]] tumors(tumors present in region of [[pituitary stalk]])
#*[[Hypothyroidism]]<ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418  }} </ref>
#*[[Hypothyroidism]]<ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418  }} </ref>
Line 34: Line 33:
#**[[Verapamil]]<ref name="pmid6682619">{{cite journal| author=Fearrington EL, Rand CH, Rose JD| title=Hyperprolactinemia-galactorrhea induced by verapamil. | journal=Am J Cardiol | year= 1983 | volume= 51 | issue= 8 | pages= 1466-7 | pmid=6682619 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6682619  }} </ref>
#**[[Verapamil]]<ref name="pmid6682619">{{cite journal| author=Fearrington EL, Rand CH, Rose JD| title=Hyperprolactinemia-galactorrhea induced by verapamil. | journal=Am J Cardiol | year= 1983 | volume= 51 | issue= 8 | pages= 1466-7 | pmid=6682619 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=6682619  }} </ref>
{| class="wikitable"
{| class="wikitable"
! colspan="4" |Prolactinoma must be differentiated from causes of hyperprolactinemia
|-
!Disease
!Disease
!Clinical Findings
!Clinical Findings
Line 123: Line 124:
|-
|-
|[[Chronic renal failure]]
|[[Chronic renal failure]]
|There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure are:
|There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure includes:
* [[Malaise]]
* [[Malaise]]
* [[nausea]]
* [[nausea]]
Line 130: Line 131:
* [[lower extremity edema]]
* [[lower extremity edema]]
* [[sleep disorders]]
* [[sleep disorders]]
|[[Renal function tests]]
|[[Urinalysis]]:
* [[Albuminuria]]
 
* [[Hematuria]]
* [[Pyuria]]
* Red cell or white cell [[casts]] and crystals
Fluid and Electrolyte disturbances:
* [[Hyponatremia]]
* [[Hyperkalemia]]
* [[Hyperphosphatemia]]
* [[Hyperchloremia]]
* [[Metabolic acidosis]]
* [[Hypocalcemia]]
Endocrine and Metabolic disturbances
* [[Hyperuricemia]]
* [[Hypertriglyceridemia]]
* Decreased [[HDL]] levels
* [[Vitamin D deficiency]]
* Increased [[Parathyroid hormone]] levels
Hematologic abnormalities
* [[Normocytic normochromic anemia]]
* [[Lymphocytopenia]]
* [[Leukopenia]]
* [[Thrombocytopenia]]
 
|
|
* Medical management:  
* Medical management:  
Line 142: Line 167:
** [[Kidney transplant]]
** [[Kidney transplant]]
|-
|-
|[[Cirrhosis]]
|[[Cirrhosis|Liver disease: Cirrhosis]]
|
|The clinical features of liver cirrhosis are very non-specific. These includes:
|[[Liver function tests]]
* Right upper quadrant [[abdominal pain]]
|
* [[Fever]]
|-
* [[Fatigue]] and [[weakness]]
|[[Viral hepatitis]]
* [[Loss of appetite]]
|
* [[Diarrhea]]
|Viral markers
* [[Nausea]] and [[vomiting]]
* [[Weight loss]]
* [[Abdominal pain]] and bloating when fluid accumulates in the abdomen
* [[Itching]]
* Menstrual irregularities
|Elevated [[aminotransferases]] ([[Aspartate transaminase|AST]] & [[Alanine transaminase|ALT]])
Elevated [[alkaline phosphatase]] ([[Alkaline phosphatase|ALP]])
 
Elevated [[gamma-glutamyl transpeptidase]]
 
Elevated [[bilirubin]]
 
Low [[albumin]]
 
Elevated [[prothrombin time]]
 
Elevated [[globulin]]
 
[[Hyponatremia]]
 
[[Anemia]]
 
[[Leukopenia]] and [[neutropenia]]
 
[[Thrombocytopenia]]
 
|
|
* Medical management:
** Treatment is directed directed most of the times towards the treatment of complications like [[ascites]], [[esophageal varices]], [[hepatic encephalopathy]], [[hepatorenal syndrome]], [[spontaneous bacterial peritonitis]].
*** Some chronic constitutional symptoms that should be treated includes:
**** [[Pruritis]]: [[Cholestyramine]] is the drug of choice
**** [[Hypogonadism]]: Topical [[testosterone]] preparations
**** [[Osteoporosis]]: [[Calcium]] and [[vitamin D]]
**** Pain management: [[Non-steroidal anti-inflammatory drug|NSAIDS]], [[celecoxib]], [[opioids]]
**** Nutrition: Adequate calories, proteins and multivitamin supplementation
* Surgical management: [[Liver transplantation]]
|-
|-
|[[Seizure|Seizure disorder]]
|[[Seizure|Seizure disorder]]
|
|The clinical feature of [[seizure disorder]] includes:
* Change in [[alertness]]; the person cannot remember a period of time
 
* Mood changes, such as unexplainable fear, panic, joy, or laughter
* Change in sensation of the skin, usually spreading over the arm, leg, or trunk
* [[Vision]] changes, including seeing flashing lights
* Rarely, [[Hallucination|hallucinations]] (seeing things that aren't there)
* Falling, loss of muscle control, occurs very suddenly
* [[Muscle twitching]] that may spread up or down an arm or leg
* Muscle tension or tightening that causes twisting of the body, head, arms, or legs
* Shaking of the entire body
* Tasting a bitter or metallic flavor
|[[Electroencephalogram]]
|[[Electroencephalogram]]
|
|
* Medical management:
** [[Antiepileptics|Antiepileptic]] medications
|-
|[[Medication-induced]]
|Clinical features of [[hyperprolactinemia]] after a specific period of regular medication ingestion
|Stop the medication and see if symptoms resolve
|Change to alternate medication
|}
|}



Revision as of 18:57, 20 July 2017

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma differential diagnosis

CDC on Prolactinoma differential diagnosis

Prolactinoma differential diagnosis in the news

Blogs on Prolactinoma differential diagnosis

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Prolactinoma must be differentiated from other causes of hyperprolactinemia.

Causes of hyperprolactinemia can be categorized as physiological, pathological and medication-induced.

Differential Diagnosis

Prolactinoma must be differentiated from other causes of hyperprolactinemia including:

  1. Physiological:
  2. Pathological:Pituitary tumors (other than prolactinoma):[2]
  3. Medication-induced:
Prolactinoma must be differentiated from causes of hyperprolactinemia
Disease Clinical Findings Laboratory findings Management
Somatotroph adenoma:

Acromegaly

Clinical features of acromegaly are due to high level of human growth hormone(hGH):
  • Soft tissue swelling of the hands and feet
  • Surgical management:
    • Endonasal transsphenoidal surgery
  • Radiation therapy
Corticotroph adenoma: Cushing's syndrome Clinical features of Cushing's syndrome are due to increased level of cortisol:
  • Dexamethasone suppression test
  • 24 hour urinary measurement of cortisol
Hypothyroidism Clinical features of hypothyroidism are due to deficiency of thyroxine:
  • Fullness in the throat and neck
  • Elevated TSH
  • Low T4
  • Low T3
  • Elevated Anti-thyroid antibodies(TPOAb)
Levothyroxine
Chronic renal failure There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure includes: Urinalysis:

Fluid and Electrolyte disturbances:

Endocrine and Metabolic disturbances

Hematologic abnormalities

Liver disease: Cirrhosis The clinical features of liver cirrhosis are very non-specific. These includes: Elevated aminotransferases (AST & ALT)

Elevated alkaline phosphatase (ALP)

Elevated gamma-glutamyl transpeptidase

Elevated bilirubin

Low albumin

Elevated prothrombin time

Elevated globulin

Hyponatremia

Anemia

Leukopenia and neutropenia

Thrombocytopenia

Seizure disorder The clinical feature of seizure disorder includes:
  • Change in alertness; the person cannot remember a period of time
  • Mood changes, such as unexplainable fear, panic, joy, or laughter
  • Change in sensation of the skin, usually spreading over the arm, leg, or trunk
  • Vision changes, including seeing flashing lights
  • Rarely, hallucinations (seeing things that aren't there)
  • Falling, loss of muscle control, occurs very suddenly
  • Muscle twitching that may spread up or down an arm or leg
  • Muscle tension or tightening that causes twisting of the body, head, arms, or legs
  • Shaking of the entire body
  • Tasting a bitter or metallic flavor
Electroencephalogram
Medication-induced Clinical features of hyperprolactinemia after a specific period of regular medication ingestion Stop the medication and see if symptoms resolve Change to alternate medication

References

  1. Rigg LA, Lein A, Yen SS (1977). "Pattern of increase in circulating prolactin levels during human gestation". Am J Obstet Gynecol. 129 (4): 454–6. PMID 910825.
  2. Levy A (2004). "Pituitary disease: presentation, diagnosis, and management". J Neurol Neurosurg Psychiatry. 75 Suppl 3: iii47–52. doi:10.1136/jnnp.2004.045740. PMC 1765669. PMID 15316045.
  3. Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH (1973). "Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone". J Clin Invest. 52 (9): 2324–9. doi:10.1172/JCI107421. PMC 333037. PMID 4199418.
  4. Sievertsen GD, Lim VS, Nakawatase C, Frohman LA (1980). "Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure". J Clin Endocrinol Metab. 50 (5): 846–52. doi:10.1210/jcem-50-5-846. PMID 7372775.
  5. Jha SK, Kannan S (2016). "Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional study". Int J Appl Basic Med Res. 6 (1): 8–10. doi:10.4103/2229-516X.173984. PMC 4765284. PMID 26958514.
  6. Ben-Menachem, Elinor (2006). "Is Prolactin a Clinically Useful Measure of Epilepsy?". Epilepsy Currents. 6 (3): 78–79. doi:10.1111/j.1535-7511.2006.00104.x. ISSN 1535-7597.
  7. David SR, Taylor CC, Kinon BJ, Breier A (2000). "The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia". Clin Ther. 22 (9): 1085–96. doi:10.1016/S0149-2918(00)80086-7. PMID 11048906.
  8. McCallum RW, Sowers JR, Hershman JM, Sturdevant RA (1976). "Metoclopramide stimulates prolactin secretion in man". J Clin Endocrinol Metab. 42 (6): 1148–52. doi:10.1210/jcem-42-6-1148. PMID 777023.
  9. Sowers JR, Sharp B, McCallum RW (1982). "Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man". J Clin Endocrinol Metab. 54 (4): 869–71. doi:10.1210/jcem-54-4-869. PMID 7037817.
  10. Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A (1976). "Effects of methyldopa on prolactin and growth hormone". Br Med J. 1 (6019): 1186–8. PMC 1639736. PMID 1268617.
  11. Fearrington EL, Rand CH, Rose JD (1983). "Hyperprolactinemia-galactorrhea induced by verapamil". Am J Cardiol. 51 (8): 1466–7. PMID 6682619.

Template:WikiDoc Sources